See complete details about this RFA

The International Progressive MS Alliance is pleased to announce a new funding initiative designed to accelerate the development of behavioral therapeutic interventions for progressive multiple sclerosis (MS) through innovation and collaboration.

This RFA is a planning grant that provides time and resources to develop ideas, construct your research team, and collect preliminary data (if needed) to ultimately develop and present an efficacy research proposal. At the end of this 15-month award, the deliverable will be a proposal for up to a 5 year efficacy trial (stage 2 of this research pipeline) focused on progressive MS.